Cellectar Biosciences Inc (NASDAQ: CLRB) on Monday, plunged -10.25% from the previous trading day, before settling in for the closing price of $4.0. Within the past 52 weeks, CLRB’s price has moved between $3.70 and $66.00.
A company in the Healthcare sector has jumped its sales by 40.27% annually for the last half of the decade. The company achieved an average annual earnings per share of 66.91%. With a float of $2.96 million, this company’s outstanding shares have now reached $3.19 million.
Cellectar Biosciences Inc (CLRB) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cellectar Biosciences Inc is 7.25%, while institutional ownership is 3.33%. The most recent insider transaction that took place on Jul 02 ’25, was worth 49,900. In this transaction Chief Executive Officer of this company bought 10,000 shares at a rate of $4.99, taking the stock ownership to the 11,638 shares. Before that another transaction happened on Jul 02 ’25, when Company’s Chief Operating Officer bought 10,000 for $4.99, making the entire transaction worth $49,900. This insider now owns 12,768 shares in total.
Cellectar Biosciences Inc (CLRB) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -11.1 earnings per share (EPS) for the period topping the consensus outlook (set at -11.2) by 0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 66.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.51% during the next five years compared to 40.27% growth over the previous five years of trading.
Cellectar Biosciences Inc (NASDAQ: CLRB) Trading Performance Indicators
Cellectar Biosciences Inc (CLRB) is currently performing well based on its current performance indicators. A quick ratio of 2.15 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.40, a number that is poised to hit -2.53 in the next quarter and is forecasted to reach -9.08 in one year’s time.
Technical Analysis of Cellectar Biosciences Inc (CLRB)
Let’s dig in a bit further. During the last 5-days, its volume was 0.97 million. That was better than the volume of 0.22 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 10.55%.
During the past 100 days, Cellectar Biosciences Inc’s (CLRB) raw stochastic average was set at 0.58%, which indicates a significant decrease from 3.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.35 in the past 14 days, which was lower than the 0.58 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.95, while its 200-day Moving Average is $7.22. However, in the short run, Cellectar Biosciences Inc’s stock first resistance to watch stands at $3.84. Second resistance stands at $4.10. The third major resistance level sits at $4.25. If the price goes on to break the first support level at $3.43, it is likely to go to the next support level at $3.28. The third support level lies at $3.02 if the price breaches the second support level.
Cellectar Biosciences Inc (NASDAQ: CLRB) Key Stats
Market capitalization of the company is 11.46 million based on 3,192K outstanding shares. Right now, sales total 0 K and income totals -44,580 K. The company made 0 K in profit during its latest quarter, and -5,450 K in sales during its previous quarter.
